Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival.
about
Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients.Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?Cellular immunotherapy of cancer: an overview and future directions.Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation.Toxicity and Immunogenicity in Murine Melanoma following Exposure to Physical Plasma-Derived Oxidants.Autologous peripheral blood mononuclear cell recognition of autologous proliferating tumor cells in the context of a patient-specific vaccine trial.
P2860
Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Resistance to the proapoptotic ...... ith improved overall survival.
@en
Resistance to the proapoptotic ...... ith improved overall survival.
@nl
type
label
Resistance to the proapoptotic ...... ith improved overall survival.
@en
Resistance to the proapoptotic ...... ith improved overall survival.
@nl
prefLabel
Resistance to the proapoptotic ...... ith improved overall survival.
@en
Resistance to the proapoptotic ...... ith improved overall survival.
@nl
P2093
P2860
P1476
Resistance to the proapoptotic ...... ith improved overall survival.
@en
P2093
A N Cornforth
A W Fowler
D J Carbonell
R O Dillman
P2860
P2888
P304
P356
10.1007/S00262-010-0925-Y
P577
2010-10-20T00:00:00Z